BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET Life Science Investing
BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal Pharmaceutical Investing
New Survey Offers Perspective on Mental and Emotional Journey for Patients Diagnosed with Slow-Growing Blood Cancer Pharmaceutical Investing
Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV Pharmaceutical Investing
Treatment With Hepcludex® Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks Pharmaceutical Investing
MAVIRET® Approved by Health Canada for Paediatric Patients with Chronic Hepatitis C Pharmaceutical Investing
Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin Life Science Investing
Sirona Biochem Contracts WuXi AppTec to Manufacture Revolutionary Anti-Aging/Anti-Wrinkle Compound for Clinical Trial Company News
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress 2022 Pharmaceutical Investing
